A spectacular effect of tocilizumab in Takayasu arteritis
Background: Anti-interleukin-6 receptors (anti-IL-6R) have been a promising new therapeutic alternative in the treatment of Takayasu arteritis. Case description: We report the case of a 34-year-old patient with Takayasu arteritis diagnosed in 2017. While she was on corticosteroid and methotrexate, t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2024-11-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4868 |